Evonik completes acquisition of Tippecanoe Laboratories in USA

08-Jan-2010 - Evonik Industries AG has completed the purchase of the Tippecanoe Laboratories manufacturing facility in Lafayette (Indiana, USA) from Eli Lilly and Company, Indianapolis (USA). The deal was closed on January 1, 2010. It was agreed not to disclose details of the purchase price. The site has a ...

Evonik strengthens its exclusive synthesis business in US

Evonik acquires Eli Lilly and Company’s U.S. Tippecanoe manufacturing site

21-Oct-2009 - Evonik Industries AG has agreed to acquire Indianapolis, Indiana-based Eli Lilly and Company’s Tippecanoe Laboratories manufacturing facility in Lafayette, Indiana. The site, which employs about 700, manufactures active pharmaceutical ingredients (API) and precursor materials for the ...

Chemists synthesize herbal alkaloid

20-Apr-2009 - The club moss Lycopodium serratum is a creeping, flowerless plant used in homeopathic medicine to treat a wide variety of ailments. It contains a potent brew of alkaloids that have attracted considerable scientific and medical interest. However, the plant makes many of these compounds in ...

CMC Acquires Former ICOS Biologics Operation in Bothell, Washington State, USA

CMC Biopharmaceuticals to purchase facility from Lilly; will retain existing employees

05-Dec-2007 - CMC Biopharmaceuticals A/S (CMC) announced that it has reached an agreement to buy the biologics development and manufacturing operation that Eli Lilly and Company acquired when it purchased ICOS Corporation in January 2007. CMC, a Copenhagen based leading provider of contract biomanufacturing ...

Lilly Announces New Employee Policy

Privacy and protection of genetic information essential for improved patient care

11-May-2007 - Eli Lilly and Company announced an expansion of its employee policies to include protection of genetic information. This addition to Lilly's privacy and nondiscrimination policies ensures an employee's genetic information cannot be used to discriminate against them when making employment choices ...

Lilly Announces Acquisition of Hypnion

Deal shall bolster Lilly's Sleep Disorder Research with promising insomnia compound

07-Mar-2007 - Eli Lilly and Company and Hypnion, Inc. announced that they have signed a definitive merger agreement whereby Lilly will acquire Hypnion, a privately held neuroscience drug discovery company focused on sleep disorders. The transaction has received the requisite approval of Hypnion stockholders ...

ICOS Shareholders Vote to Approve Merger With Eli Lilly

29-Jan-2007 - ICOS Corporation (ICOS) announced that its shareholders approved the revised Agreement and Plan of Merger whereby Eli Lilly and Company will acquire all of the outstanding stock of ICOS for a purchase price of $34 per share in cash. There was a strong turnout at the meeting, with 77.0 percent of ...

Alkermes and Lilly Expand AIR Inhaled Insulin Collaboration

10-Jan-2007 - Alkermes, Inc. and Eli Lilly and Company announced that they have signed a commercial manufacturing agreement for AIR® Inhaled Insulin (AIR® Insulin). As a result of the agreement, Alkermes will be the exclusive commercial manufacturer of AIR Insulin powder for the AIR® Inhaled Insulin System ...

ICOS Announces Revised Merger Agreement With Lilly

20-Dec-2006 - ICOS Corporation announced that an agreement has been reached to amend the terms of the merger agreement with Eli Lilly and Company, which was originally signed on October 16, 2006. The revised Agreement and Plan of Merger provides that Lilly will acquire all of the outstanding common stock of ...

Lilly acquires ICOS Corporation for $2.1 Billion

19-Oct-2006 - Eli Lilly and Company announced that it has signed a definitive merger agreement to acquire ICOS Corporation in a cash transaction. Under the terms of the agreement, Lilly will acquire all of the outstanding shares of ICOS common stock at a price of $32 per share, for a total of approximately ...